Physician profile
Benjamin Geyman
NPI 1114625993
$771.27
in general payments reported to CMS, 2019-2025
16 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $220 · 2024: $244 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $219.90 | 2023-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $154.77 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $59.33 | 2025 | Rexulti |
| Medtronic, INC. | $45.15 | 2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Lilly USA, LLC | $42.91 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Xeris Pharmaceuticals, INC. | $37.44 | 2024-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $32.43 | 2023-2024 | |
| Nevro Corp. | $27.22 | 2023 | Senza |
| Globus Medical, INC. | $27.03 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.02 | 2024 | Jardiance |
| Exact Sciences Corporation | $19.50 | 2023 | Cologuard Collection Kit |
| Insulet Corporation | $17.12 | 2023 | Omnipod |
| Pfizer INC. | $16.88 | 2025 | |
| Abbott Laboratories | $16.46 | 2024 | Freestyle Libre 3 |
| Boston Scientific Corporation | $14.58 | 2025 | Bodyguardian |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.53 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Geyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.